Literature DB >> 30597657

AHNS Series - Do you know your guidelines?: Assessment and management of malnutrition in patients with head and neck cancer: Review of the NCCN Clinical Practice Guidelines In Oncology (NCCN Guidelines).

Amarbir Gill1, Babak Givi2, Michael G Moore1.   

Abstract

This article is a part of the "Do you know your guidelines" series by the Education Committee of the American Head and Neck Society. The aim is to summarize the core principles outlined by the NCCN Clinical Practice Guidelines In Oncology (NCCN Guidelines® ) on management of malnutrition in patients with head and neck cancer. We outline the current recommendations from the National Comprehensive Cancer Network® (NCCN® ) for the screening and management of malnutrition, including indications for nutritional supplementation and placement of a nasogastric or gastrostomy tube. We also include a brief review of the available literature on additional screening tools, alternative guidelines, as well as an update on the emerging data surrounding the use of immune-enhancing nutrition.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  guidelines; head and neck cancer; malnutrition; nutrition

Year:  2018        PMID: 30597657     DOI: 10.1002/hed.24866

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  8 in total

1.  From Budd-Chiari syndrome to acquired von Willebrand syndrome: thrombosis and bleeding complications in the myeloproliferative neoplasms.

Authors:  Brady L Stein; Karlyn Martin
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 2.  Quality of life after low-dose rate-brachytherapy for prostate carcinoma - long-term results and literature review on QLQ-C30 and QLQ-PR25 results in published brachytherapy series.

Authors:  Daniel Buergy; Vincent Schneiberg; Joerg Schaefer; Grit Welzel; Lutz Trojan; Christian Bolenz; Frederik Wenz
Journal:  Health Qual Life Outcomes       Date:  2018-01-22       Impact factor: 3.186

3.  Advantages of using reduced-volume intensity modulated radiation therapy for the treatment of nasopharyngeal carcinoma: a retrospective paired study.

Authors:  Fang Liu; Ting Luo; Tao Jin; Jiahui Zhang; Zhongzheng Xiang; Ruonan Yan; Li Xie; Xin Wu; Hong Zhang; Feng Wang; Ping Li; Lei Liu
Journal:  BMC Cancer       Date:  2019-06-08       Impact factor: 4.430

4.  Definitive radiochemotherapy in esophageal cancer - a single institution experience.

Authors:  Franc Anderluh; Miha Toplak; Vaneja Velenik; Irena Oblak; Ajra Secerov Ermenc; Ana Jeromen Peressutti; Jasna But-Hadzic; Marija Skoblar Vidmar
Journal:  Radiol Oncol       Date:  2019-11-20       Impact factor: 2.991

5.  Pretreatment Plasma EBV-DNA Load Guides Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Cancer: A Meta-Analysis.

Authors:  Lin Lai; Xinyu Chen; Chuxiao Zhang; Xishan Chen; Li Chen; Ge Tian; Xiaodong Zhu
Journal:  Front Oncol       Date:  2021-02-16       Impact factor: 6.244

6.  Risk Signature Related to Immunotherapy Reaction of Hepatocellular Carcinoma Based on the Immune-Related Genes Associated With CD8+ T Cell Infiltration.

Authors:  Yiping Zou; Zhihong Chen; Hongwei Han; Shiye Ruan; Liang Jin; Yuanpeng Zhang; Zhengrong Chen; Zuyi Ma; Qi Lou; Ning Shi; Haosheng Jin
Journal:  Front Mol Biosci       Date:  2021-03-19

7.  Non-osseous soft tissue metastasis in the foot from renal cell carcinoma.

Authors:  Nusrat Jahan; Shabnam Rehman
Journal:  BMJ Case Rep       Date:  2020-10-22

8.  Geographical disparities in the prognosis of patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: a large institution-based cohort study from an endemic area.

Authors:  Si-Ting Lin; Dong-Fang Meng; Qi Yang; Wei Wang; Li-Xia Peng; Li-Sheng Zheng; Yuan-Yuan Qiang; Yan Mei; Liang Xu; Chang-Zhi Li; Xing-Si Peng; Hao Hu; Yan-Hong Lang; Zhi-Jie Liu; Ming-Dian Wang; Hai-Feng Li; Bi-Jun Huang; Chao-Nan Qian; Rui Sun
Journal:  BMJ Open       Date:  2020-11-10       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.